NTR
Nutrien Ltd
Nutrien Ltd historical holders
total: 4
Fairholme Capital Management Nutrien Ltd transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q4
Bruce Berkowitz has been an institutional investor in Nutrien Ltd (NTR) since 2021 Q3. According to 2026 Q1 report, Bruce Berkowitz doesn't hold any shares. The fund/company first acquired NTR in 2021 Q3, initially purchasing 20,000 shares. Since the initial investment, Fairholme Capital Management has made 1 more transaction in this position.
When did Bruce Berkowitz exit their NTR position?
Bruce Berkowitz no longer holds Nutrien Ltd (NTR). They sold off their entire position in 2021 Q4, closing out an investment that began in 2021 Q3.
When did Bruce Berkowitz first invest in NTR?
Bruce Berkowitz first invested in Nutrien Ltd (NTR) in 2021 Q3 at the reported quarter-end price of $64.85 per share, acquiring 20,000 shares in their initial purchase.
What is Bruce Berkowitz's average cost basis for NTR?
Based on historical transaction data, Bruce Berkowitz's estimated cost basis for Nutrien Ltd (NTR) is approximately $64.85 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $64.85
- Weighted AVG sell price:
- $64.85
NTR transactions history by Fairholme Capital Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$64.85
|
|
-100% (-20,000)
|
-0.1%
|
|
2021 Q3
|
0.10%
|
20,000
|
$64.85
|
$1,297,000
|
new
|
+0.1%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.